General Information of the Compound
Compound ID
CP0564593
Compound Name
8-[6-[3-(5-methylpyrazol-1-yl)propoxy]pyrimidin-4-yl]-2,5-dioxa-8-azaspiro[3.5]nonane
    Show/Hide
Structure
Formula
C17H23N5O3
Molecular Weight
345.403
Canonical SMILES
Cc1ccnn1CCCOc1cc(ncn1)N1CCOC2(COC2)C1
    Show/Hide
InChI
InChI=1S/C17H23N5O3/c1-14-3-4-20-22(14)5-2-7-24-16-9-15(18-13-19-16)21-6-8-25-17(10-21)11-23-12-17/h3-4,9,13H,2,5-8,10-12H2,1H3
    Show/Hide
InChIKey
ALYBZGIJTIELKM-UHFFFAOYSA-N
Physicochemical Property
logP
1.05622
Rotatable Bonds
6
Heavy Atom Count
25
Polar Areas
74.53
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
8
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 166633210
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT05231, Very long chain fatty acid elongase 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 120 nM
   TI
   LI
   LO
   TS